- Home
- PPC vs PEN Comparison
PPC vs PEN Comparison
Compare PPC & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPC
- PEN
- Stock Information
- Founded
- PPC 1946
- PEN 2004
- Country
- PPC United States
- PEN United States
- Employees
- PPC N/A
- PEN N/A
- Industry
- PPC Meat/Poultry/Fish
- PEN Medical/Dental Instruments
- Sector
- PPC Consumer Staples
- PEN Health Care
- Exchange
- PPC Nasdaq
- PEN Nasdaq
- Market Cap
- PPC 10.4B
- PEN 10.6B
- IPO Year
- PPC 1987
- PEN 2015
- Fundamental
- Price
- PPC $42.32
- PEN $256.28
- Analyst Decision
- PPC Hold
- PEN Strong Buy
- Analyst Count
- PPC 4
- PEN 16
- Target Price
- PPC $47.50
- PEN $302.93
- AVG Volume (30 Days)
- PPC 1.4M
- PEN 466.4K
- Earning Date
- PPC 10-29-2025
- PEN 10-29-2025
- Dividend Yield
- PPC 19.82%
- PEN N/A
- EPS Growth
- PPC 62.69
- PEN 916.05
- EPS
- PPC 5.19
- PEN 3.74
- Revenue
- PPC $18,177,417,000.00
- PEN $1,280,152,000.00
- Revenue This Year
- PPC $3.72
- PEN $15.52
- Revenue Next Year
- PPC $0.72
- PEN $14.20
- P/E Ratio
- PPC $8.17
- PEN $68.21
- Revenue Growth
- PPC 2.06
- PEN 12.92
- 52 Week Low
- PPC $41.17
- PEN $185.07
- 52 Week High
- PPC $57.16
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- PPC 32.40
- PEN 42.85
- Support Level
- PPC $41.95
- PEN $270.54
- Resistance Level
- PPC $44.12
- PEN $280.14
- Average True Range (ATR)
- PPC 1.08
- PEN 7.98
- MACD
- PPC -0.15
- PEN -2.80
- Stochastic Oscillator
- PPC 10.60
- PEN 9.11
About PPC Pilgrim's Pride Corporation
Pilgrim's Pride is the second-largest poultry producer in the US (59% of 2024 sales), the UK (29% including other European sales), and Mexico (12%). Its UK and European arm also includes pork operations from the 2019 acquisition of Tulip. Pilgrim's sells to chain restaurants, food processors, food distributors, and retail chains. Most of its US and Mexican sales come from fresh chicken, while prepared chicken and pork constitute most of its UK and European sales. JBS owns more than 80% of Pilgrim's Pride's outstanding shares, though it failed to acquire the remaining stake in 2021 after a special board committee deemed that JBS' offer undervalued Pilgrim's Pride.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.